C10orf90 and metastatic malignant neoplasm in the lymph nodes: The low expression of FATS is associated with lymph node metastasis states and predicts the poor clinical outcome of NSCLC patients17, but little is known regarding the role of FATS in metabolic reprogramming in NSCLC.